Value proposition

Enabling same-day cancer diagnostics from minimally invasive sample material

X-ZELL is an award-winning medical technology start-up specialising in next-generation cytology.

Cytology – or cytopathology – is the science of diagnosing diseases by examining single atypical cells or cell clusters.

X-ZELL has developed a plug-and-play solution for the detection, visualization and digitization of these phenomena in minimally invasive body liquids.

Slotting seamlessly into clinical routine, it does not require complex specimen preparation and reduces the average time from sample to diagnosis from 48h to less than 4h.

The result: better diagnostics and improved patient care.

X-ZELL is headquartered in Singapore and has regional offices in Germany (Europe), Thailand (Southeast Asia) and the US (North America).

Biotechnology, Cancer Detection, Liquid Biopsy, Medical Device Development, Immunostaining, Health Technology, Med Tech, Digital Health, AI, Cryobiology, Single Cell Diagnostics, and Screening